FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387403005: Medrysone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1763823011 Medrysone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1776060018 Medrysone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
823221000172111 médrysone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medrysone (substance) Is a Adrenal cortex hormone true Inferred relationship Some
Medrysone (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Adrenal cortex hormone (disposition) true Inferred relationship Some
Medrysone (substance) Is a Hormone false Inferred relationship Some
Medrysone (substance) Is a Glucocorticoid hormone false Inferred relationship Some
Medrysone (substance) Is a Glucocorticoid (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Medrysone 10 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medrysone (substance) Inferred relationship Some
Product containing medrysone in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medrysone (substance) Inferred relationship Some 1
Product containing medrysone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medrysone (substance) Inferred relationship Some 1
Medrysone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medrysone (substance) Inferred relationship Some 1
Product containing only medrysone in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medrysone (substance) Inferred relationship Some 1
Medrysone 10 mg/mL eye suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medrysone (substance) Inferred relationship Some 1
Medrysone 10 mg/mL eye suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medrysone (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start